Menu Close

Guthrie: Vaccine is making progress

While still a ways away from mass production, a vaccine for COVID-19 may soon be approved. In a recent interview, 2nd District Representative Brett Guthrie says 3 different versions are nearing trial completion. 

2nd District Rep. Brett Guthrie

One trial that is currently underway that Guthrie highlighted is Pfizer, which he says is conducting a 30,000 patient study. Guthrie says that, while a mass rollout is still expected for the first of the year, those who would receive it first would be frontline healthcare workers, the elderly, as well as those with comorbidities.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *